Skip to search formSkip to main contentSkip to account menu

RC 160

Known as: RC-160 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

vapreotide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Lipophilization of somatostatin analog RC‐160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro
The therapeutic potential of the somatostatin analogue RC‐160 having antiproliferative activity, is limited by its short serum… 
Highly Cited
1992
Highly Cited
1992
Inhibition of growth of PC‐82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC‐3095 or combination of agonist [D‐Trp6]‐luteinizing hormone‐releasing hormone and…
The effects of treatment with a bombesin receptor antagonist [D‐Tpi6, Leu13Ψ(CH2NH) Leu14]BN(6–14)(RC‐3095) and the combination… 
1992
1992
Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC‐160
Hepatic metastases of colon 320 DM and WidR human colon cancers in nude mice were treated by s.c. injections of somatostatin… 
Review
1992
Review
1992
Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer.
1991
1991
Somatostatin analogue rc‐160 inhibits the growth of transplanted colon cancer in rats
The effect of somatostatin analogue RC‐160 on the growth of DHD/K12 rat colon cancer has been investigated in vivo as well as in… 
Highly Cited
1991
Highly Cited
1991
Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates…
Analogues of somatostatin (SS) and luteinizing hormone-releasing hormone (LH-RH) activate tyrosine phosphatases in MIA PaCa-2… 
Review
1990
Review
1990
Growth factor-receptor pathway interfering treatment by somatostatin analogs and suramin: Preclinical and clinical studies
1989
1989
Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.
Antitumoral effects of the agonist of luteinizing hormone-releasing hormone (D-Trp-6-LH-RH) and the somatostatin analog RC-160 (D… 
1989
1989
Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160
]SummaryThe effect of treatment with D-Trp-6-LH-RH, an agonist of luteinizing hormone-releasing hormone (LHRH), and somatostatin… 
1987
1987
Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)